Pacira BioSciences (PCRX) EPS (Basic) (2010 - 2026)
Pacira BioSciences (PCRX) posted EPS (Basic) of $0.12 for Q2 2026, up 63.61% on a QoQ basis from $0.07 in Q1 2026, and up 210.59% year-over-year from $0.04 in Q2 2025.
Powered by 
Analysis
Pacira BioSciences (PCRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Pacira BioSciences has reported EPS (Basic) for 17 years, with the latest figure at $0.12 in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 210.59% year-over-year to $0.12 in Q2 2026; TTM through Jun 2026 was $0.37, a 113.23% increase from a year earlier, with the FY2025 full-year figure at $0.16, up 107.33% from the prior year.
- EPS (Basic) was $0.12 for Q2 2026 at Pacira BioSciences, up from $0.07 in the prior quarter.
- The five-year high for EPS (Basic) was $0.56 in Q2 2023, with the low at -$3.11 in Q3 2024.
- Average EPS (Basic) over 5 years is -$0.03, with a median of $0.12 recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) surged 1647.06% in 2023, then sank 1429.37% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.22 in 2022, then soared by 342.46% to $0.54 in 2023, then sank by 35.53% to $0.35 in 2024, then sank by 89.41% to $0.04 in 2025, then jumped by 221.0% to $0.12 in 2026.
- The last three EPS (Basic) figures came in at $0.12 (Q2 2026), $0.07 (Q1 2026), and $0.04 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.35 Bn | 624.59 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 440.82 Bn | 434.25 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.35 Bn | 357.21 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.35 Bn | 258.66 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.51 Bn | 45.13 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | -3.06 |
| 8 | Incyte | 25.30 Bn | 20.76 Bn | 1.57 Bn | 2.92 |
| 9 | United Therapeutics | 21.40 Bn | 18.73 Bn | 683.80 Mn | 7.82 |
| 10 | Pacira BioSciences | 1.01 Bn | 757.82 Mn | 148.24 Mn | 0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | -3.11 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.54 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | -0.12 |
| Sep 30, 2021 | 0.40 |